Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease.

Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease.
Related ArticlesInner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson's disease. Sci Rep. 2019 Aug 14;9(1):11832 Authors: Sung MS, Choi SM, Kim J, Ha JY, Kim BC, Heo H, Park SW Abstract We investigated the association between retinal changes measured using optical coherence tomography (OCT) and diverse clinical grading scales in patients with Parkinson's disease (PD). ... read more
Source: PubMedPublished on 2019-08-16